{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7203,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "transition",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/23",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a red dashed box to highlight the primary efficacy metrics (response rates).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/24",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart uses a grouped bar structure to compare efficacy across patient segments (No BCMA, Yes BCMA, Overall).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/25",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a comparison table framework to highlight competitive advantage in clinical metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/26",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a two-column layout to compare clinical data for two different indications, supported by competitor market data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/27",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart illustrates deepening responses over time in a clinical trial setting.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/28",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The table displays clinical trial data for NXC-201, specifically focusing on Cytokine Release Syndrome (CRS) and Immune cell associated Neurotoxicity (ICANS).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/29",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "peer_benchmark",
      "function": "compare_peers",
      "notes": "The slide highlights specific safety metrics (CRS and ICANS) for two dosage groups (100x10^6 and 300x10^6 cells).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/30",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Includes FDA approval precedents in the footer.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/31",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The diagram illustrates a classic dose-escalation study design.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/32",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "testimonial",
      "function": "illustrate_case",
      "notes": "The slide uses a mix of expert quotes and a comparative table of clinical trials to validate the outpatient therapy thesis.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/33",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "section_divider",
      "function": "transition",
      "notes": "The slide features a scientific illustration of cellular structures, likely representing the drug delivery mechanism.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/34",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes scientific diagrams of molecular pathways and efficacy charts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/35",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Slide contains three distinct data visualizations comparing IMX-110 against standard of care or historical benchmarks.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/36",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes a process flow diagram illustrating the mechanism of action of iMX-110 in turning cold tumors hot.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/37",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes survival curves, median survival comparison, and bioluminescence imaging of tumor activity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/38",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "transition",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/39",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-39",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 40,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes waterfall chart for best percentage change and line charts for longitudinal tumor size tracking against PD/PR thresholds.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/40",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-40",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a scatter plot to map clinical trial outcomes (mPFS vs. prior lines of therapy) and a table to detail standard-of-care performance across lines of therapy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/41",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 42,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a combination of a conceptual chart and a data table to highlight efficacy and safety in a late-stage patient population.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/42",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-42",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 43,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Includes logos for BeiGene and Novartis at the bottom.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/43",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-43",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/44",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a process-flow style layout to connect platform capabilities to specific therapeutic assets.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/45",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 45,
          "from": 28,
          "beatId": "683cd8f0-b72b-44cb-97c1-04c1b9a9d852",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The deck highlights the benefits and potential of Immix Biopharma's therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a process-like structure to map the platform pillars to specific product outputs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/46",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 58,
          "from": 46,
          "beatId": "4e07e972-cafc-486f-912e-2418cf212a13",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action and future plans",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 47,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes technical diagrams of the drug molecule, comparative histology, and survival curves.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/47",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-47",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 58,
          "from": 46,
          "beatId": "4e07e972-cafc-486f-912e-2418cf212a13",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action and future plans",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 48,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes two sets of charts: tumor volume line graphs and survival curves. References specific dosing schedules and study parameters.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/48",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-48",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 58,
          "from": 46,
          "beatId": "4e07e972-cafc-486f-912e-2418cf212a13",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action and future plans",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 49,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a combination of mechanism-of-action diagrams and clinical/preclinical data charts to validate the therapeutic approach.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/49",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-49",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 58,
          "from": 46,
          "beatId": "4e07e972-cafc-486f-912e-2418cf212a13",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action and future plans",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 50,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/50",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-50",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 58,
          "from": 46,
          "beatId": "4e07e972-cafc-486f-912e-2418cf212a13",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action and future plans",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 51,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide is divided into two sections: ImmixBio Clinical Advisory Board and Select Nexcella Scientific Advisory Board Members.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/51",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-51",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 58,
          "from": 46,
          "beatId": "4e07e972-cafc-486f-912e-2418cf212a13",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action and future plans",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 52,
      "slideType": "team_bio",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/52",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-52",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 58,
          "from": 46,
          "beatId": "4e07e972-cafc-486f-912e-2418cf212a13",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action and future plans",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}